United States Diabetes Drugs Market Report 2016

◆商品コード:QYR61232989
◆発行会社(リサーチ会社):QYResearch
◆発行日:2016年10月24日
◆ページ数:123
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ
◆産業分野:電子・電気
◆販売価格オプション(消費税別)
Single UserUSD3,800 ⇒換算¥418,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD7,600 ⇒換算¥836,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Notes:Sales, means the sales volume of Diabetes Drugs
Revenue, means the sales value of Diabetes Drugs

This report studies sales (consumption) of Diabetes Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Novo Nordisk
Sanofi
MSD
Eli Lilly
Medtronic
Novartis
ASTRAZENECA
Takada
Bristol-Myers Squibb
BOEHRINGER INGELHEIM
Insulet
TANDEM
NCPC Corp.
Huadong Medicine
Dongbao Group
Hisun
Hisun
Ginwa
Guizhou Tianan Pharmaceutical
JUMCAN

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Insulin
Non-sulin
Type III
Split by applications, this report focuses on sales, market share and growth rate of Diabetes Drugs in each application, can be divided into
Application 1
Application 2
Application 3

【レポートの目次】

Table of Contents

United States Diabetes Drugs Market Report 2016
1 Diabetes Drugs Overview
1.1 Product Overview and Scope of Diabetes Drugs
1.2 Classification of Diabetes Drugs
1.2.1 Insulin
1.2.2 Non-sulin
1.2.3 Type III
1.3 Application of Diabetes Drugs
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Diabetes Drugs (2011-2021)
1.4.1 United States Diabetes Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Diabetes Drugs Revenue and Growth Rate (2011-2021)

2 United States Diabetes Drugs Competition by Manufacturers
2.1 United States Diabetes Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Diabetes Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Diabetes Drugs Average Price by Manufactures (2015 and 2016)
2.4 Diabetes Drugs Market Competitive Situation and Trends
2.4.1 Diabetes Drugs Market Concentration Rate
2.4.2 Diabetes Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Diabetes Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Diabetes Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Diabetes Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Diabetes Drugs Price by Type (2011-2016)
3.4 United States Diabetes Drugs Sales Growth Rate by Type (2011-2016)

4 United States Diabetes Drugs Sales (Volume) by Application (2011-2016)
4.1 United States Diabetes Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Diabetes Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Diabetes Drugs Manufacturers Profiles/Analysis
5.1 Novo Nordisk
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Diabetes Drugs Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Novo Nordisk Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Sanofi
5.2.2 Diabetes Drugs Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Sanofi Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 MSD
5.3.2 Diabetes Drugs Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 MSD Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Eli Lilly
5.4.2 Diabetes Drugs Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Eli Lilly Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Medtronic
5.5.2 Diabetes Drugs Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Medtronic Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Novartis
5.6.2 Diabetes Drugs Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Novartis Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 ASTRAZENECA
5.7.2 Diabetes Drugs Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 ASTRAZENECA Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Takada
5.8.2 Diabetes Drugs Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Takada Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Bristol-Myers Squibb
5.9.2 Diabetes Drugs Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Bristol-Myers Squibb Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 BOEHRINGER INGELHEIM
5.10.2 Diabetes Drugs Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 BOEHRINGER INGELHEIM Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Insulet
5.12 TANDEM
5.13 NCPC Corp.
5.14 Huadong Medicine
5.15 Dongbao Group
5.16 Hisun
5.17 Hisun
5.18 Ginwa
5.19 Guizhou Tianan Pharmaceutical
5.20 JUMCAN

6 Diabetes Drugs Manufacturing Cost Analysis
6.1 Diabetes Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Diabetes Drugs

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Diabetes Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Diabetes Drugs Market Forecast (2016-2021)
10.1 United States Diabetes Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Diabetes Drugs Sales Forecast by Type (2016-2021)
10.3 United States Diabetes Drugs Sales Forecast by Application (2016-2021)
10.4 Diabetes Drugs Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Tables and Figures

Figure Picture of Diabetes Drugs
Table Classification of Diabetes Drugs
Figure United States Sales Market Share of Diabetes Drugs by Type in 2015
Figure Insulin Picture
Figure Non-sulin Picture
Table Application of Diabetes Drugs
Figure United States Sales Market Share of Diabetes Drugs by Application in 2015
Figure United States Diabetes Drugs Sales and Growth Rate (2011-2021)
Figure United States Diabetes Drugs Revenue and Growth Rate (2011-2021)
Table United States Diabetes Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Diabetes Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Diabetes Drugs Sales Share by Manufacturers
Figure 2016 Diabetes Drugs Sales Share by Manufacturers
Table United States Diabetes Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Diabetes Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Diabetes Drugs Revenue Share by Manufacturers
Table 2016 United States Diabetes Drugs Revenue Share by Manufacturers
Table United States Market Diabetes Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Diabetes Drugs Average Price of Key Manufacturers in 2015
Figure Diabetes Drugs Market Share of Top 3 Manufacturers
Figure Diabetes Drugs Market Share of Top 5 Manufacturers
Table United States Diabetes Drugs Sales by Type (2011-2016)
Table United States Diabetes Drugs Sales Share by Type (2011-2016)
Figure United States Diabetes Drugs Sales Market Share by Type in 2015
Table United States Diabetes Drugs Revenue and Market Share by Type (2011-2016)
Table United States Diabetes Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Diabetes Drugs by Type (2011-2016)
Table United States Diabetes Drugs Price by Type (2011-2016)
Figure United States Diabetes Drugs Sales Growth Rate by Type (2011-2016)
Table United States Diabetes Drugs Sales by Application (2011-2016)
Table United States Diabetes Drugs Sales Market Share by Application (2011-2016)
Figure United States Diabetes Drugs Sales Market Share by Application in 2015
Table United States Diabetes Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Diabetes Drugs Sales Growth Rate by Application (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Diabetes Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Diabetes Drugs Sales Market Share (2011-2016)
Table MSD Basic Information List
Table MSD Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table MSD Diabetes Drugs Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Diabetes Drugs Sales Market Share (2011-2016)
Table Medtronic Basic Information List
Table Medtronic Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic Diabetes Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Diabetes Drugs Sales Market Share (2011-2016)
Table ASTRAZENECA Basic Information List
Table ASTRAZENECA Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ASTRAZENECA Diabetes Drugs Sales Market Share (2011-2016)
Table Takada Basic Information List
Table Takada Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takada Diabetes Drugs Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Diabetes Drugs Sales Market Share (2011-2016)
Table BOEHRINGER INGELHEIM Basic Information List
Table BOEHRINGER INGELHEIM Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table BOEHRINGER INGELHEIM Diabetes Drugs Sales Market Share (2011-2016)
Table Insulet Basic Information List
Table Insulet Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Insulet Diabetes Drugs Sales Market Share (2011-2016)
Table TANDEM Basic Information List
Table TANDEM Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table TANDEM Diabetes Drugs Sales Market Share (2011-2016)
Table NCPC Corp. Basic Information List
Table NCPC Corp. Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table NCPC Corp. Diabetes Drugs Sales Market Share (2011-2016)
Table Huadong Medicine Basic Information List
Table Huadong Medicine Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Huadong Medicine Diabetes Drugs Sales Market Share (2011-2016)
Table Dongbao Group Basic Information List
Table Dongbao Group Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dongbao Group Diabetes Drugs Sales Market Share (2011-2016)
Table Hisun Basic Information List
Table Hisun Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hisun Diabetes Drugs Sales Market Share (2011-2016)
Table Hisun Basic Information List
Table Hisun Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hisun Diabetes Drugs Sales Market Share (2011-2016)
Table Ginwa Basic Information List
Table Ginwa Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ginwa Diabetes Drugs Sales Market Share (2011-2016)
Table Guizhou Tianan Pharmaceutical Basic Information List
Table Guizhou Tianan Pharmaceutical Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Guizhou Tianan Pharmaceutical Diabetes Drugs Sales Market Share (2011-2016)
Table JUMCAN Basic Information List
Table JUMCAN Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table JUMCAN Diabetes Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetes Drugs
Figure Manufacturing Process Analysis of Diabetes Drugs
Figure Diabetes Drugs Industrial Chain Analysis
Table Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2015
Table Major Buyers of Diabetes Drugs
Table Distributors/Traders List
Figure United States Diabetes Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Diabetes Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Diabetes Drugs Production Forecast by Type (2016-2021)
Table United States Diabetes Drugs Consumption Forecast by Application (2016-2021)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ United States Diabetes Drugs Market Report 2016]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆